Position in BBIO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,463,532
+$65,588 QoQ
Shares Held
19,650
+4.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#207
of 469 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2026CallValue
$74,480
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $29,586,127 across 12 Biotechnology names. BBIO ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
251,215 | $19,918,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,315 | $2,067,035 | |
| 3 | CSBR |
Champions Oncology, Inc.
|
295,658 | $1,821,253 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
This page
|
19,650 | $1,463,532 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
77,700 | $1,049,727 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
31,250 | $1,043,437 | |
| 7 | IMMX |
Immix Biopharma, Inc.
|
88,550 | $912,950 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
2,300 | $562,971 |
All Filings in BBIO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,480 | 1,000 | Call | Sole | 2026-08-10 | |
| 2026-06-30 | $1,463,532 | 19,650 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,397,944 | 18,825 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $74,260 | 1,000 | Call | Sole | 2026-05-12 | |
| 2025-12-31 | $1,436,099 | 18,775 | Shares | Sole | 2026-02-12 | |
| 2025-12-31 | $76,490 | 1,000 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $975,173 | 18,775 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $809,625 | 18,750 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $658,558 | 19,050 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $520,674 | 18,975 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $450,642 | 17,700 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $385,016 | 15,200 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $392,684 | 12,700 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $540,958 | 13,400 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $374,454 | 14,200 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $331,100 | 19,250 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $365,589 | 22,050 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||